Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #815

    Langers Skarpe: Investorerne forlader tech, health care og biotek
    https://www.proinvestor.com/investornyt/673079/langers-skarpe-investorerne-forlader-tech-health-care-og-biotek

    1 Reply Last reply
    0
    • SolsenS Offline
      SolsenS Offline
      Solsen
      wrote on sidst redigeret af
      #816

      ...og der kommer andre ind. 😉

      1 Reply Last reply
      0
      • G Offline
        G Offline
        gentogen
        wrote on sidst redigeret af
        #817

        BMS har 6 aktive studier med nivolumab og IL8. High levels of serum IL-8 are associated with a poor prognosis in various tumors (Sanmamed, MF, et al. Clin Cancer Res. 2014;20:5697-5707), such as melanoma, non-squamous small cell lung cancer (NSCLC), and renal cell carcinoma, and decreases in serum IL-8 levels have been suggested to be associated with response to anti–PD-(L)1 therapy with nivolumab

        1 Reply Last reply
        0
        • G Offline
          G Offline
          gentogen
          wrote on sidst redigeret af
          #818

          Just a moment...

          favicon

          (ascopubs.org)

          1 Reply Last reply
          0
          • P Offline
            P Offline
            peter12
            wrote on sidst redigeret af
            #819

            Plus dette for CV19 https://clinicaltrials.gov/ct2/show/NCT04347226

            1 Reply Last reply
            0
            • P Offline
              P Offline
              peter12
              wrote on sidst redigeret af
              #820

              Hvis man søger på IL8 i chatten, nævner nogle Genmab opt-in 50/50 eller 25 royalties. Måske nogen kan afkræfte det ? Det er lidt svært at se årstal på beskederne https://borsen.dk/nyheder/virksomheder/genmab-droppede-laegemidlet-nu-scorer-svenskere-milliarder-paa-salg-4eeua

              1 Reply Last reply
              0
              • P Offline
                P Offline
                peter12
                wrote on sidst redigeret af
                #821

                25%

                1 Reply Last reply
                0
                • D Offline
                  D Offline
                  Doublo
                  wrote on sidst redigeret af
                  #822

                  Peter12 der står 6/7 2016 under billedet af JVW kan der være det?

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    peter12
                    wrote on sidst redigeret af
                    #823

                    Nej det var vist artiklen. Jeg tænkte på det man finder hvis man søger i chatten

                    1 Reply Last reply
                    0
                    • D Offline
                      D Offline
                      Doublo
                      wrote on sidst redigeret af
                      #824

                      Det eneste sted jeg ser IL8 nævnt er i pipelinen hos Genmab HuMax-IL8 partnership Bristol-Myers Squibb Company Target:IL8 advanced cancers phase 1 pre-clinical, jeg ved dog kke om, det er det du skriver om Peter12?

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Stockwatch1
                        wrote on sidst redigeret af
                        #825

                        DnB opjusterer Genmab til Buy fra Sell

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Stockwatch1
                          wrote on sidst redigeret af
                          #826

                          DnB hæver kursmålet til 2360 fra 2250

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Stockwatch1
                            wrote on sidst redigeret af
                            #827

                            DnB: Following the recent share price decline, the arbitration
                            case now looks more than factored in, and with strong
                            pipeline news flow likely in 2021 we have turned
                            positive on Genmab, believing it is time for investors to
                            position themselves in the name.

                            1 Reply Last reply
                            0
                            • DarvinD Offline
                              DarvinD Offline
                              Darvin
                              wrote on sidst redigeret af
                              #828

                              Aftalen vedr IL8 er fra 2012 og indeholder engangsbetaling, milestones ved hver udvikling og royalties. Husker ikke satserne, men mindes at der har været spurgt til det https://ir.genmab.com/static-files/04d12578-aeee-4d4d-b9e2-b3e4e999d8ed

                              1 Reply Last reply
                              0
                              • DarvinD Offline
                                DarvinD Offline
                                Darvin
                                wrote on sidst redigeret af
                                #829

                                Videreført til BMS I 2016

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  peter12
                                  wrote on sidst redigeret af
                                  #830

                                  Tror ikke der er nogen der kender tallet @pensionist

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #831

                                    God morgen. 🙂

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #832

                                      Asien: Frygt for stramninger sender kinesiske aktier ned https://www.proinvestor.com/investornyt/673088/asien-frygt-for-stramninger-sender-kinesiske-aktier-ned

                                      1 Reply Last reply
                                      0
                                      • bongobobB Offline
                                        bongobobB Offline
                                        bongobob
                                        wrote on sidst redigeret af
                                        #833

                                        Angående IL8 fra SEC rapportering: "We are entitled to receive up to a total of €10.0 million in licensing and sales milestones and royalty payments in the low-single digits on net sales of the HuMax-IL8 product by BMS and a percentage in the low-double digits to high-teens range on license income from any BMS sublicensee(s)."

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #834

                                          Mandagens danske avisuddrag med AP Pension, greenwashing og Rockwoolhttps://www.proinvestor.com/investornyt/673092/mandagens-danske-avisuddrag-med-ap-pension-greenwashing-og-rockwool

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger